Our vision is to be the leading company in the field of reproductive healthcare in Indonesia and a world class player in injectable contraceptives.
The heart of our vision lies in our mission to make readily accessible the highest quality products at affordable prices, thus contributing to the welfare, well-being and quality of life of the communities we serve both domestically and regionally.
Supported by its vast experience of partnerships with numerous leading multinational pharmaceutical companies for more than 30 years,
PT TUNGGAL IDAMAN ABDI plays a very important role in developing and maintaining the national drug standard, with particular emphasis in contraceptives and reproductive health products.
We also actively participate and support the national family planning program by collaborating with The Indonesian National Population and Family Planning Board / BKKBN, producing millions of vials of quarterly injectable contraceptive / DMPA.
Additionally, being a member of The Generic Manufacturers for Reproductive Health or GEMS, which is a community of practice comprised of a select group of generic manufacturers that collectively distribute family planning products to more than 50 countries,
PT TUNGGAL IDAMAN ABDI is united in its commitment to provide the safe, quality-assured family planning products that enable women to make choices about their reproductive health.
The GEMS Caucus currently comprises seven select pharmaceutical companies from Asia, Africa and Europe, including
PT TUNGGAL IDAMAN ABDI as the only member from Indonesia.
Furthermore, PT TUNGGAL IDAMAN ABDI is the only Indonesian manufacturer selected as a member of Reproductive Health Supplies Coalition, which is a global partnership of public, private, and non-governmental organizations working together to ensure that all people can choose, access and use affordable, high-quality reproductive health products. The Supplies Coalition has been at the forefront of international efforts to secure reproductive health supplies by increasing resources, strengthening systems, and building effective partnerships.
Our mission is to be the leading global provider of reproductive healthcare drugs, with particular emphasis on injectable contraceptives. With over 50 years of experience in producing US FDA approved contraceptives, today we are producing millions of our injectable contraceptives to cater both the domestic as well as exports markets. Currently exporting to over 45 countries, we are expanding our global distribution network whilst simultaneously passing multiple adults by the local drug authority agencies in the destination countries.